Apimeds expects NYSE notice for late 10-K filing; targets April 30

Apimeds Pharmaceuticals US, Inc.

Filed Form 12b-25 on March 31, 2026 for FY 2025 10-K; will not file within 15-day extension.
Expects NYSE American non-compliance notice due to failure to timely file 10-K.
Plans to file 10-K by April 30, 2026; no assurance given.
Delay driven by ongoing preparation of financial statements and audit completion.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.